Home » PROTOX THERAPEUTICS ANNOUNCES PRESENTATION OF DATA AT LEADING CANCER RESEARCH CONFERENCE
PROTOX THERAPEUTICS ANNOUNCES PRESENTATION OF DATA AT LEADING CANCER RESEARCH CONFERENCE
Protox Therapeutics Inc. announced today that preclinical data demonstrating
PRX302's validity as a treatment for prostate cancer and benign prostatic hyperplasia
(BPH) is being presented in a poster session at the 97th Meeting of the American
Association of Cancer Research (AACR), which is being held this week at the
Washington Convention Centre in Washington, D.C.
CNW
Group
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May